Mectizan as a stimulus for development of novel partnerships: the international governing bodys perspective
 B Y D. E. ETYAALE * Programm e for the Prevention of Blindness, globe Health Organization, CH 1211, Geneva 27, Switzerland Received and accepted 23 October 1997
pastime the free donation of Mectizan (ivermectin, MSD) by Merck & Co. in 1987, early efforts to circumstances distri barelye the drug came from non-governmental development organizations (NGDO), which had already established projects in Africa and Latin America by 1989. In the beginning, these projects were NGDO-speci® c and slightly independent from one another. Subsequently, the collect to co-ordinate all attempts at Mectizan distribution led to the creation of the Onchocerciasis Eradication course of instruction of the Americas (OEPA), in 1991, and the NGDO Co-ordination Group for Ivermectin Distribution, in 1992. The latter was to become the ` apex mover in Mectizan-distribution programmes, particularly in areas of Africa not monitored by the Onchocerciasis Control Programme in West Africa (OCP), until the approach of the African Programme for Onchocerciasis Control (APOC) in 1995.
erst the co-ordination group had been established and its co-ordinator appointed, the Mectizan-distribution programme expanded rapidly, reaching 7 million people by 1995. However, the limited resources of the co-ordination group and the need to achieve a better co-ordinated and more comprehensive run of onchocerciasis ultimately led to the creation of the APOC in 1995. The international co-operation behind the APOC has inaugurated a unique type of global partnership, in which the success of the programme lies not with a single player, but with close working relationships and collaboration between many partners: donors; governments of endemic countries; NGDO; international organizations; and private institutions. This is a complex process, the success...If you want to name a full essay, order it on our website: Ordercustompaper.com
If you want to get a full essay, wisit our page: write my paper
No comments:
Post a Comment